On or around 04/21/2017 (Other)
Filing Date: March 28, 2017
According to the Complaint, this action stems from a proposed transaction announced on January 24, 2017 (the “Proposed Transaction”), pursuant to which GenVec, Inc. (“GenVec” or the “Company”) will be acquired by Intrexon Corporation (“Parent”) and Intrexon GV Holding, Inc. (“Merger Sub,” and together with Parent, “Intrexon”). On January 24, 2017, GenVec’s Board of Directors (the “Board” or “Individual Defendants”) caused the Company to enter into an agreement and plan of merger (the “Merger Agreement”) with Intrexon.
On March 17, 2016, defendants filed a Form S-4 Registration Statement (the “Registration Statement”) with the United States Securities and Exchange Commission (“SEC”) in connection with the Proposed Transaction. The Complaint alleges the Registration Statement, which recommends that GenVec’s stockholders vote in favor of the Proposed Transaction, omits material information with respect to the Proposed Transaction, which renders the Registration Statement false and misleading.
This case was voluntarily dismissed on April 19, 2017.
Company & Securities Information
Defendant: GenVec, Inc.
Industry: Biotechnology & Drugs
Headquarters: United States
Ticker Symbol: GNVC
Company Market: NASDAQ
Market Status: Public (Listed)
About the Company & Securities Data
"Company" information provides the industry and sector classification and headquarters state for the primary company-defendant in the litigation. In general, "Securities" information provides the ticker symbol, market, and market status for the underlying securities at issue in the litigation.
In most cases, the primary company-defendant actually issued the securities that are the subject of the litigation, and the securities information and company information relate to the same entity. In a small subset of cases, however, the primary company-defendant is not the issuer (for example, cases against third party brokers/dealers), and the securities information and company information do not relate to the same entity.